This month’s research article is about sentinel lymph node biopsy (SLNB), and is in the form of a viewpoint from two clinicians at the centre of excellence that is Memorial Sloan Kettering Cancer Center in New York. Continue reading “[10 min read] Sentinel lymph node biopsy: Where do we stand?” →

Welcome to this podcast series, Conversations with Professor David Wilkinson! In this episode, Prof David Wilkinson (Deputy Vice-Chancellor at Macquarie University) speaks with Dr Francis Tan – a dedicated Skin Cancer Doctor who has practised in the field since 1994 – about daylight photodynamic therapy as a front-line treatment for actinic keratosis. Continue reading “[Podcast] Treating actinic keratosis with daylight photodynamic therapy | Conversations with Prof David Wilkinson” →

While surgical excision is usually the first choice for treating skin cancer, there are times when a non-surgical approach is favourable. In this short video, HealthCert presenter and Skin Cancer Doctor Hamilton Ayres talks about the different non-surgical options and situations where these might be appropriate. Continue reading “[3 min watch] When to use non-surgical treatments for skin cancer” →

Do you use LED phototherapy in your practice, or do you wish to utilise its full potential in treating a range of skin concerns? In this webinar, Skin Cancer and Aesthetic Medicine Doctor Di King shares how light emitting diode (LED) can be used to treat a range of common dermatological presentations, including acne, superficial skin lesions, and wound healing. Continue reading “[WEBINAR] LED phototherapy in skin cancer, general dermatology and aesthetic medicine” →

Nodular basal cell carcinoma (BCC) is most often treated with surgical excision. However, interest is increasing in minimally invasive treatments for these low-risk skin cancers. A new study reviewed the effectiveness of surgical excision compared with curettage and imiquimod cream in treating nodular BCC. Continue reading “[2 min read] Surgery vs curettage & imiquimod for nodular BCC” →

Treating actinic keratosis is very common in general practice, and especially so in primary care skin cancer medicine. Many patients require treatment of both individual lesions (for example, by cryotherapy) and of the whole field that is affected (for example, the whole face, using a topical treatment, or a field treatment more generally). Continue reading “[2 min read] Field treatments for actinic keratosis | Prof David Wilkinson” →

How effective and safe is photodynamic therapy in treating Bowen’s disease? Bowen’s disease is an intraepidermal squamous cell carcinoma (SCC). There are several alternatives for treatment of Bowen’s disease, including photodynamic therapy. A new study investigated the efficacy and safety of photodynamic therapy in treating the skin condition. Continue reading “[3 min read] Photodynamic therapy for Bowen’s disease” →

New research suggests that the success of immunotherapy for melanoma can be predicted before treatment begins. A common issue with immunotherapies is that a drug that works well in many patients may have little effect in other patients with the same cancer type. But researchers have now identified new markers that can help predict which patients will have a better chance of responding positively to immunotherapy treatments. Continue reading “[6 min read] Can we predict melanoma immunotherapy success?” →

The new Non-Melanoma Skin Cancer Guidelines have been released. A PDF summary of the key recommendations is helpfully provided, which is well worth a read and important to become familiar with. Continue reading “[2 min read] New cryotherapy guidelines | Prof David Wilkinson” →

The outer layer of the skin completely replaces itself every two to four weeks, but when this process is blocked, cancer can grow. A new study from researchers at the University of Pennsylvania has now identified a key regulator of that block known as LSD1, as well as a way to genetically influence the skin to grow in a way that prevents this block from happening. Continue reading “[4 min read] Blocking key regulator could treat non-melanoma skin cancers” →